BCH — on-the-record assessments

Across 14 months and 5 orders no substitution, reformulation or post-payment unavailability was encountered by this assessor.

Documentation was complete at first issue. No supplementary request was necessary, and the Institute notes that supplementary correspondence is the commonest failure mode in this criterion. The assessor declares no interest in the supplier beyond the transactions described.

This assessor has placed 9 orders across 10 months and holds documentation for each. The set is internally consistent. This is a single assessor’s record and carries the weight the rubric assigns to one.

Cold-chain integrity was maintained through transit; the phase-change pack remained solid to arrival on day 3. No adverse finding arises from the transactions described.

Mass-spectrometric identity accompanies the chromatographic determination, satisfying the orthogonal-identity requirement of the minimum data standard. Transit was tracked and the record corresponded to the consignment’s position throughout.

Packing was assessed as adequate to the transit undertaken: a rigid outer with no rattle anywhere in it. The submission is recorded in full in the evidence log.

A custom-synthesis engagement was completed 2 days inside the quoted schedule, at the purity specified in the signed specification. Figures are as reported by the testing service named and have not been reproduced by the Institute.

Consistency across lots was assessed over 8 determinations. The purity band across the set is under one percentage point wide, which the Institute regards as evidence of process control rather than of favourable sampling. The assessor has placed subsequent orders with the same supplier.

The declared figure was not adjusted upward between the certificate and the commercial documentation. Discrepancies of this kind are specifically screened for. Nothing in this submission constitutes medical advice.

The reorder placed some months later returned a purity figure within a tenth of a point of the original. Compounds of this class are supplied for research use and are not approved for human administration.

Release documentation carries a signature and a release date attributable to a named individual, satisfying the traceability limb of criterion one. Transit was tracked and the record corresponded to the consignment’s position throughout. Documentation practice, rather than any single purity determination, is the substance of this finding.

Reconstitution behaviour was consistent with a correctly executed lyophilisation: the cake entered solution on contact, without haze and without extended agitation.

Fill uniformity was assessed by weighing 8 units from a single consignment against declared fill. All units fell within two per cent of the declared mass.

A repeat determination on the same catalogue line at 14 months returned 97.8%, against 97.8% originally. No evidence of process drift is present in this sample.

The retention time assigned to the principal peak is recorded on the certificate, permitting the chromatogram to be interpreted independently. No excipient was present and the lyophilised cake was intact. Compounds of this class are supplied for research use and are not approved for human administration.

A supplementary certificate covering a lot released 14 months previously was produced from the supplier’s records on request, indicating that release records are retained rather than reconstructed. The gradient and column chemistry are stated, permitting the determination to be reproduced.

Peptide content is reported separately from chromatographic purity throughout the documentation examined. The distinction is maintained consistently across the 10 certificates held. Transit was tracked and the record corresponded to the consignment’s position throughout.

Delivery was completed on day 2 against a quoted 2 days from stock held in the United States. Customs documentation was correct at first presentation. Catalogue availability corresponded to the published catalogue. No adverse finding arises from the transactions described.

The independent report for the lot was retrievable by batch number without correspondence. Independent verification of an individual lot remains necessary irrespective of this record.

The order acknowledgement stated the dispatching warehouse, which allows the transit history of the lot to be reconstructed. Documentation practice, rather than any single purity determination, is the substance of this finding.

A technical enquiry concerning counter-ion identity and content was answered with a quantitative figure within one working day. Responses of this character are recorded because they are uncommon. Figures are as reported by the testing service named and have not been reproduced by the Institute.

Water content is reported by Karl Fischer titration with the determination method named, which the rubric requires and which a minority of suppliers provide. The gradient and column chemistry are stated, permitting the determination to be reproduced. The assessor has placed subsequent orders with the same supplier.

Purity is declared by a stability-indicating chromatographic method, and the method, column chemistry and detection wavelength are all named on the certificate. The declaration is therefore assessable. Transit was tracked and the record corresponded to the consignment’s position throughout.

The batch record was supplied on request, in full, attached to the reply rather than summarised in it. Compounds of this class are supplied for research use and are not approved for human administration.

Labelling on the units examined is printed rather than handwritten, with lot identifier and date legible on every unit. Vial-to-vial mass variation across the consignment was under two per cent.

Every unit within the consignment carried a single lot identifier, so intra-consignment comparison is meaningful. The technical response was received within four hours on a working day. The finding covers the lots named and is not generalised beyond them.